Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Small cell carcinoma of the larynx: results of therapy.
Solé J, Jürgens A, Musulén E, Lacasta A, Guedea F, Quer M, Leon X, Lopez Pousa A, Lerma E. Solé J, et al. Bull Cancer Radiother. 1994;81(1):45-8. Bull Cancer Radiother. 1994. PMID: 7893523 Review.
Mortality and biochemical recurrence after surgery, brachytherapy, or external radiotherapy for localized prostate cancer: a 10-year follow-up cohort study.
Suárez JF, Zamora V, Garin O, Gutiérrez C, Pont À, Pardo Y, Goñi A, Mariño A, Hervás A, Herruzo I, Cabrera P, Sancho G, Ponce de León J, Macías V, Guedea F, Vigués F, Castells M, Ferrer M; Multicentric Spanish Group of Clinically Localized Prostate Cancer. Suárez JF, et al. Sci Rep. 2022 Jul 22;12(1):12589. doi: 10.1038/s41598-022-16395-w. Sci Rep. 2022. PMID: 35869124 Free PMC article.
Role of boost radiotherapy for local control of pure ductal carcinoma in situ after breast-conserving surgery: a multicenter, retrospective study of 622 patients.
Cambra MJ, Moreno F, Sanz X, Anglada L, Mollà M, Reyes V, Arenas M, Pedro A, Ballester R, García V, Casals J, Cusidó M, Jimenez C, Escribà JM, Macià M, Solé JM, Arcusa A, Seguí MA, Gonzalez S, Farrús B, Biete A. Cambra MJ, et al. Among authors: sole jm. Clin Transl Oncol. 2020 May;22(5):670-680. doi: 10.1007/s12094-019-02168-x. Epub 2019 Jul 1. Clin Transl Oncol. 2020. PMID: 31264148
Phase I study of concurrent chemoradiation with pemetrexed and cisplatin followed by consolidation pemetrexed for patients with unresectable stage III non-small cell lung cancer.
Cardenal F, Arnaiz MD, Morán T, Jové J, Nadal E, Porta R, Solé JM, Brao I, Palmero R, Fuentes R, Núñez I, Caveda E, Cassinello A. Cardenal F, et al. Among authors: sole jm. Lung Cancer. 2011 Oct;74(1):69-74. doi: 10.1016/j.lungcan.2011.01.021. Epub 2011 Feb 24. Lung Cancer. 2011. PMID: 21353323 Clinical Trial.
Adaptation and validation of the Spanish version of the Patient-Oriented Prostate Utility Scale (PORPUS).
Avila M, Pardo Y, Castells M, Ferrer F, Boladeras A, Pera J, Prada PJ, Guix B, de Paula B, Hernandez H, Pont A, Alonso J, Garin O, Bremner K, Krahn M, Ferrer M; Multicentric Spanish Group of Clinically Localized Prostate Cancer. Avila M, et al. Qual Life Res. 2014 Nov;23(9):2481-7. doi: 10.1007/s11136-014-0701-0. Epub 2014 May 1. Qual Life Res. 2014. PMID: 24789667 Free article.
Induction chemotherapy with cisplatin and gemcitabine followed by concurrent chemoradiation with twice-weekly gemcitabine in unresectable stage III non-small cell lung cancer: final results of a phase II study.
Blanco R, Solé J, Montesinos J, Mesía C, Algara M, Terrassa J, Gay M, Domenech M, Bastus R, Bover I, Nogué M, Vadell C; ACROSS. Blanco R, et al. Among authors: sole j. Lung Cancer. 2008 Oct;62(1):62-71. doi: 10.1016/j.lungcan.2008.02.024. Epub 2008 Apr 25. Lung Cancer. 2008. PMID: 18440089 Clinical Trial.
High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial.
Zapatero A, Guerrero A, Maldonado X, Álvarez A, San-Segundo CG, Rodríguez MÁC, Solé JM, Olivé AP, Casas F, Boladeras A, de Vidales CM, de la Torre MLV, Vara S, Sanz JL, Calvo FA. Zapatero A, et al. Among authors: sole jm. Lancet Oncol. 2022 May;23(5):671-681. doi: 10.1016/S1470-2045(22)00190-5. Epub 2022 Apr 12. Lancet Oncol. 2022. PMID: 35427469 Clinical Trial.
146 results